Table 4 The differential metabolites in SMMC-7721 cell and medium after treatment of CKI. *p < 0.05, **p < 0.01, ***p < 0.001 versus untreated cells.

From: Uncovering the anticancer mechanism of Compound Kushen Injection against HCC by integrating quantitative analysis, network analysis and experimental validation

No

Metabolites

CKI cell

fold change

CKI medium

fold change

1

Leucine

↑**

4.00

↓***

1.97

2

Valine

↑**

5.39

↓***

1.60

3

Acetate

↑***

4.81

  

4

Lactate

  

↓***

5.25

5

Pyruvate

  

↑***

4.91

6

Succinate

  

↑***

2.17

7

Pyroglutamate

  

↑***

2.29

8

Glutamate

↓***

2.98

  

9

Glutamine

↑**

1.52

  

10

Glutathione

↓***

4.10

  

11

Creatine

↓**

2.61

  

12

GPCc

↓**

2.57

  

13

Glycine

↓***

2.91

↑***

1.67

14

Threonine

  

↑***

12.76

15

1,3-Dihydroxyacetone

↓**

2.01

  

16

Glycerol

↑***

2.31

↑**

2.08

17

Alanine

  

↑***

1.32

18

Adenosine monophosphate

↓*

1.52

  

19

β-Glucose

↑**

11.05

  

20

Tyrosine

↑***

3.69

  

21

Phenylalanine

↑***

3.34

  

22

Hypoxanthine

↓***

3.18